title: Manganese exposure alters extracellular GABA, GABA receptor and transporter protein and mRNA levels in the developing rat brain.
abstract: Unlike other essential trace elements (e.g., zinc and iron) it is the toxicity of manganese (Mn) that is more common in human populations than its deficiency. Data suggest alterations in dopamine biology may drive the effects associated with Mn neurotoxicity, though recently gamma-aminobutyric acid (GABA) has been implicated. In addition, iron deficiency (ID), a common nutritional problem, may cause disturbances in neurochemistry by facilitating accumulation of Mn in the brain. Previous data from our lab have shown decreased brain tissue levels of GABA as well as decreased (3)H-GABA uptake in synaptosomes as a result of Mn exposure and ID. These results indicate a possible increase in the concentration of extracellular GABA due to alterations in expression of GABA transport and receptor proteins. In this study weanling-male Sprague-Dawley rats were randomly placed into one of four dietary treatment groups: control (CN; 35mg Fe/kg diet), iron-deficient (ID; 6mg Fe/kg diet), CN with Mn supplementation (via the drinking water; 1g Mn/l) (CNMn), and ID with Mn supplementation (IDMn). Using in vivo microdialysis, an increase in extracellular GABA concentrations in the striatum was observed in response to Mn exposure and ID although correlational analysis reveals that extracellular GABA is related more to extracellular iron levels and not Mn. A diverse effect of Mn exposure and ID was observed in the regions examined via Western blot and RT-PCR analysis, with effects on mRNA and protein expression of GAT-1, GABA(A), and GABA(B) differing between and within the regions examined. For example, Mn exposure reduced GAT-1 protein expression by approximately 50% in the substantia nigra, while increasing mRNA expression approximately four-fold, while in the caudate putamen mRNA expression was decreased with no effect on protein expression. These data suggest that Mn exposure results in an increase in extracellular GABA concentrations via altered expression of transport and receptor proteins, which may be the basis of the neurological characteristics of manganism.
authors.affiliation: Department of Nutrition, University of North Carolina at Greensboro, Greensboro, NC 27402, USA.
authors.forename: Joel G
authors.initials: JG
authors.lastname: Anderson
authors.forename: Steve C
authors.initials: SC
authors.lastname: Fordahl
authors.forename: Paula T
authors.initials: PT
authors.lastname: Cooney
authors.forename: Tara L
authors.initials: TL
authors.lastname: Weaver
authors.forename: Christa L
authors.initials: CL
authors.lastname: Colyer
authors.forename: Keith M
authors.initials: KM
authors.lastname: Erikson
mesh_terms: D000818:Animals; D000831:Animals, Newborn; D001921:Brain / Q000187:drug effects* / Q000254:growth & development; D045604:Extracellular Fluid / Q000187:drug effects* / Q000378:metabolism; D050485:GABA Plasma Membrane Transport Proteins / Q000235:genetics / Q000378:metabolism*; D018507:Gene Expression Regulation, Developmental / Q000187:drug effects*; D008297:Male; D008345:Manganese / Q000494:pharmacology*; D012333:RNA, Messenger / Q000378:metabolism*; D051381:Rats; D017207:Rats, Sprague-Dawley; D018079:Receptors, GABA / Q000235:genetics / Q000378:metabolism*; D014131:Trace Elements / Q000494:pharmacology*; D005680:gamma-Aminobutyric Acid / Q000378:metabolism*
chemical_list: D050485:GABA Plasma Membrane Transport Proteins; D012333:RNA, Messenger; D018079:Receptors, GABA; D014131:Trace Elements; D008345:Manganese; D005680:gamma-Aminobutyric Acid
references.citation: Environ Toxicol Pharmacol. 2007 Mar;23(2):179-84
references.pmid: 17387379
references.citation: Nat Neurosci. 1999 May;2(5):467-72
references.pmid: 10321252
references.citation: Acta Pharmacol Toxicol (Copenh). 1976;39(5):562-9
references.pmid: 990038
references.citation: Anal Bioanal Chem. 2005 Jun;382(3):581-91
references.pmid: 15726336
references.citation: Trends Neurosci. 1990 Jul;13(7):259-65
references.pmid: 1695400
references.citation: J Nutr. 2001 Feb;131(2S-2):568S-579S; discussion 580S
references.pmid: 11160590
references.citation: Arch Toxicol. 1976 Aug 18;35(4):319-23
references.pmid: 989299
references.citation: J Neurosci. 2008 Jan 30;28(5):1185-97
references.pmid: 18234896
references.citation: Neurotoxicology. 1999 Apr-Jun;20(2-3):467-76
references.pmid: 10385905
references.citation: Biophys J. 1986 Oct;50(4):669-76
references.pmid: 3779006
references.citation: Am J Ind Med. 2007 Oct;50(10):772-8
references.pmid: 17620281
references.citation: Neurotoxicology. 2004 Mar;25(3):433-41
references.pmid: 15019306
references.citation: Biometals. 2003 Mar;16(1):41-54
references.pmid: 12572663
references.citation: Neurochem Int. 2002 Oct;41(4):271-7
references.pmid: 12106778
references.citation: Neurochem Res. 1999 Jul;24(7):849-56
references.pmid: 10403624
references.citation: Environ Res. 1994 Feb;64(2):151-80
references.pmid: 8306949
references.citation: J Neurosci. 2005 Mar 23;25(12):3234-45
references.pmid: 15788781
references.citation: Brain Res Bull. 1999 Oct;50(3):209-14
references.pmid: 10566983
references.citation: Biol Trace Elem Res. 2002 Summer;87(1-3):143-56
references.pmid: 12117224
references.citation: Pharmacol Biochem Behav. 2001 Jul-Aug;69(3-4):409-18
references.pmid: 11509198
references.citation: J Nutr. 2000 Aug;130(8):2040-8
references.pmid: 10917923
references.citation: Trends Neurosci. 1990 Jul;13(7):272-6
references.pmid: 1695402
references.citation: Experientia. 1989 Apr 15;45(4):343-5
references.pmid: 2565248
references.citation: FEBS Lett. 2001 Dec 7;509(2):309-16
references.pmid: 11741608
references.citation: Brain Res Brain Res Rev. 1998 May;26(2-3):148-53
references.pmid: 9651511
references.citation: Neurotoxicology. 2002 May;23(1):69-76
references.pmid: 12164549
references.citation: J Nutr. 1992 Jun;122(6):1300-8
references.pmid: 1588448
references.citation: Trends Pharmacol Sci. 2006 Jul;27(7):375-83
references.pmid: 16762425
references.citation: Neurosci Lett. 1999 Aug 13;271(1):5-8
references.pmid: 10471200
references.citation: J Neurochem. 1999 Jan;72(1):148-56
references.pmid: 9886065
references.citation: J Neurochem. 2006 Apr;97(2):310-33
references.pmid: 16539676
references.citation: Biochem Pharmacol. 2003 Jul 1;66(1):1-13
references.pmid: 12818360
references.citation: J Nutr Biochem. 2004 Jun;15(6):335-41
references.pmid: 15157939
references.citation: Arch Environ Health. 1989 May-Jun;44(3):175-8
references.pmid: 2751354
references.citation: J Nutr. 1997 Dec;127(12):2282-8
references.pmid: 9405575
references.citation: Toxicol Sci. 2007 Jan;95(1):205-14
references.pmid: 17060373
references.citation: Environ Toxicol Pharmacol. 2005 Nov;20(3):390-4
references.pmid: 21783617
references.citation: Neurosci Lett. 2003 Sep 25;349(1):13-6
references.pmid: 12946575
references.citation: J Nutr. 2000 Nov;130(11):2831-7
references.pmid: 11053528
references.citation: Environ Health Perspect. 2006 Jan;114(1):124-9
references.pmid: 16393669
references.citation: Am J Clin Nutr. 1999 Jul;70(1):37-43
references.pmid: 10393136
references.citation: Hokkaido Igaku Zasshi. 1998 May;73(3):215-25
references.pmid: 9719948
references.citation: Toxicol Sci. 2007 Jan;95(1):188-95
references.pmid: 17032702
references.citation: Neuroreport. 2005 Feb 28;16(3):307-10
references.pmid: 15706241
references.citation: Neurochem Res. 2005 Sep;30(9):1147-54
references.pmid: 16292508
references.citation: Neurosci Lett. 2006 May 1;398(1-2):151-4
references.pmid: 16417967
references.citation: Crit Rev Toxicol. 2005 Jan;35(1):1-32
references.pmid: 15742901
references.citation: J Pharmacol Exp Ther. 2005 Apr;313(1):46-55
references.pmid: 15608081
references.citation: J Neurosci Res. 2001 Mar 15;63(6):461-8
references.pmid: 11241581
references.citation: Toxicol Sci. 2006 Aug;92(2):516-25
references.pmid: 16705042
references.citation: Nature. 1997 Jul 31;388(6641):482-8
references.pmid: 9242408
references.citation: Prog Brain Res. 2007;160:43-57
references.pmid: 17499108
references.citation: Neuroscience. 1999;93(3):1189-96
references.pmid: 10473284
references.citation: J Chromatogr A. 2001 Apr 20;914(1-2):293-8
references.pmid: 11358224
references.citation: J Neurochem. 1994 Jan;62(1):205-16
references.pmid: 7505311
references.citation: Pharmacol Ther. 1995;67(2):187-246
references.pmid: 7494864
references.citation: Pharmacol Ther. 2001 Oct;92(1):21-55
references.pmid: 11750035
references.citation: Neurotoxicology. 1999 Apr-Jun;20(2-3):227-38
references.pmid: 10385886